TSC1 stabilizes TSC2 by inhibiting the interaction between TSC2 and the HERC1 ubiquitin ligase

被引:173
作者
Chong-Kopera, H
Inoki, K
Li, Y
Zhu, TQ
Garcia-Gonzalo, FR
Rosa, JL
Guan, KL [1 ]
机构
[1] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA
[4] Univ Barcelona, IDIBELL, Dept Ciencies Fisiol 2, Barcelona 08907, Spain
关键词
D O I
10.1074/jbc.C500451200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tuberous sclerosis complex ( TSC) is an autosomal dominant disease characterized by hamartoma formation in various organs. Two genes responsible for the disease, TSC1 and TSC2, have been identified. The TSC1 and TSC2 proteins, also called hamartin and tuberin, respectively, have been shown to regulate cell growth through inhibition of the mammalian target of rapamycin pathway. TSC1 is known to stabilize TSC2 by forming a complex with TSC2, which is a GTPase- activating protein for the Rheb small GTPase. We have identified HERC1 as a TSC2- interacting protein. HERC1 is a 532- kDa protein with an E3 ubiquitin ligase homology to E6AP carboxyl terminus ( HECT) domain. We observed that the interaction of TSC1 with TSC2 appears to exclude TSC2 from interacting with HERC1. Disease mutations in TSC2, which result in its destabilization, allow binding to HERC1 in the presence of TSC1. Our study reveals a potential molecular mechanism of how TSC1 stabilizes TSC2 by excluding the HERC1 ubiquitin ligase from the TSC2 complex. Furthermore, these data reveal a possible biochemical basis of how certain disease mutations inactivate TSC2.
引用
收藏
页码:8313 / 8316
页数:4
相关论文
共 30 条
  • [1] The Rheb family of GTP-binding proteins
    Aspuria, PJ
    Tamanoi, F
    [J]. CELLULAR SIGNALLING, 2004, 16 (10) : 1105 - 1112
  • [2] The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination
    Benvenuto, G
    Li, SW
    Brown, SJ
    Braverman, R
    Vass, WC
    Cheadle, JP
    Halley, DJJ
    Sampson, JR
    Wienecke, R
    DeClue, JE
    [J]. ONCOGENE, 2000, 19 (54) : 6306 - 6316
  • [3] CATALYSIS OF GUANINE-NUCLEOTIDE EXCHANGE ON RAN BY THE MITOTIC REGULATOR RCC1
    BISCHOFF, FR
    PONSTINGL, H
    [J]. NATURE, 1991, 354 (6348) : 80 - 82
  • [4] Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression
    Fingar, DC
    Blenis, J
    [J]. ONCOGENE, 2004, 23 (18) : 3151 - 3171
  • [5] Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling
    Gao, XS
    Zhang, Y
    Arrazola, P
    Hino, O
    Kobayashi, T
    Yeung, RS
    Ru, BG
    Pan, DJ
    [J]. NATURE CELL BIOLOGY, 2002, 4 (09) : 699 - 704
  • [6] The HERC proteins: functional and evolutionary insights
    Garcia-Gonzalo, FR
    Rosa, JL
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2005, 62 (16) : 1826 - 1838
  • [7] Upstream and downstream of mTOR
    Hay, N
    Sonenberg, N
    [J]. GENES & DEVELOPMENT, 2004, 18 (16) : 1926 - 1945
  • [8] Pathological mutations in TSC1 and TSC2 disrupt the interaction between hamartin and tuberin
    Hodges, AK
    Li, SW
    Maynard, J
    Parry, L
    Braverman, R
    Cheadle, JP
    DeClue, JE
    Sampson, JR
    [J]. HUMAN MOLECULAR GENETICS, 2001, 10 (25) : 2899 - 2905
  • [9] Signaling by target of rapamycin proteins in cell growth control
    Inoki, K
    Ouyang, H
    Li, Y
    Guan, KL
    [J]. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 2005, 69 (01) : 79 - +
  • [10] TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
    Inoki, K
    Li, Y
    Zhu, TQ
    Wu, J
    Guan, KL
    [J]. NATURE CELL BIOLOGY, 2002, 4 (09) : 648 - 657